Publications
August 5, 2020 Coronavirus (COVID-19) Resource Center
July 8, 2020 FDA Releases COVID-19 Vaccine Guidance for Industry
June 16, 2020 HHS Amends Tort Immunity Declaration Under the PREP Act to Clarify that Immunity Extends to Products that “Limit the Harm” COVID-19 “Might Otherwise Cause”
April 22, 2020 HHS Issues Advisory Opinion Further Clarifying Scope of PREP Act Immunity
March 24, 2020 HHS Provides Limited Tort Immunity to Companies Providing Pandemic Response Countermeasures under the PREP Act
December 11, 2019 Assessing Potential Risk: Due Diligence for Acquisition of Product Manufacturers
March 28, 2019 Toward a Global Solution on Vaccine Liability and Compensation Food and Drug Law Journal
December 17, 2018 FDA Withdraws Proposed Rule Abolishing Generic Preemption; Recognizes “Downsides” Of Expanded Tort Liability
April 20, 2018 Seventh Circuit Issues Strong Endorsement of Learned Intermediary Doctrine in Medical-Device MDL
December 12, 2017 'Accutane' Appeal Presents Opportunity for NJ to Adopt 'Daubert'
February 21, 2017 NJ Supreme Court Takes Us Back in Time on Tort Statute of Limitations
December 15, 2016 The Foreign Plaintiff Problem
December 14, 2016 Product Liability & Toxic Tort Litigation: Recent 'Reglan' Decision Chips Away at Preemption
Spring 2009 The Admission of Government Agency Reports under Federal Rule of Evidence 803(8)(c)
